Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

APTIV PLC (APTV)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Aptiv Showcasing Next Generation Intelligent Edge Solutions at Automate 2026

Market reaction Comment Full text

NEUMORA THERAPEUTICS, INC. (NMRA)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update

Market reaction Comment Full text

VONTIER CORP (VNT)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Vontier Earns Top Accolade at International Sustainability Awards

Market reaction Comment Full text

ENLIVEX LTD. (ENLV)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis

Market reaction Comment Full text

ONESPAN INC. (OSPN)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

The Shift to Digital Credentials Accelerates: OneSpan Launches Early Access at Identiverse

Market reaction Comment Full text

RECTITUDE HOLDINGS LTD. (RECT)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Rectitude Holdings Ltd Secures Additional AIMS System Orders for Major Infrastructure and Residential Projects Across Singapore

Market reaction Comment Full text

IRON HORSE ACQUISITION II CORP. (IRHO)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

ELECTRA AI to Participate in ROTHs 16th Annual London Conference, June 16-18, 2026

Market reaction Comment Full text

SEER, INC. (SEER)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction

Market reaction Comment Full text

Humacyte Inc (HUMAW)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Humacyte's Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting

Market reaction Comment Full text

HUMACYTE, INC. (HUMA)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 0
  • 1 comments

Humacytes Bioengineered Blood Vessel Outperforms the Standard of Care for Women on Dialysis in Phase 3 Results Presented at the Society for Vascular Surgery Vascular Annual Meeting

Market reaction Comment Full text
  • Previous
  • 46
  • 47
  • 48
  • 49
  • 50
  • Next

Search

News categories

  • Technical Exchange News(13154)
  • Event(6229)
  • SEC News(330597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(184309)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin